ROBERT NELSEN Insider Trading $VIR Vir Biotechnology, Inc.
Get free email notifications about insider trading for ROBERT NELSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT NELSEN. ROBERT NELSEN is in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Unity Biotechnology, Inc. ($UBX) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Juno Therapeutics, Inc. ($JUNO) and Director in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Sage Therapeutics, Inc. ($SAGE) and in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Denali Therapeutics Inc. ($DNLI) and Director in Vir Biotechnology, Inc. ($VIR) and Director in Beam Therapeutics Inc. ($BEAM) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX) and Director in Lyell Immunopharma, Inc. ($LYEL) and Director in Sana Biotechnology, Inc. ($SANA).
ROBERT NELSEN in Vir Biotechnology, Inc.
Trading Symbol: VIRIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT NELSEN: Director
Holdings: 11,832,766 shares
Latest Transaction: Apr 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT NELSEN in Vir Biotechnology, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, BEAM, BLPH, DNLI, JUNO, KRTX, KYTH, LYEL, SAGE, SANA, SNNA, SYRS, UBX, VIR
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,989 | 0 | 23,954 | 18 K to 24 K (+33.34 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,051,678 | 15.3 M to 15.1 M (-1.84 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 11,614,985 | 11.8 M to 11.6 M (-1.84 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,989 | 0 | 17,965 | 12 K to 18 K (+50.01 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,333,897 | 15.6 M to 15.3 M (-1.81 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 11,832,766 | 12.1 M to 11.8 M (-1.81 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,987 | 0 | 11,976 | 6 K to 12 K (+99.97 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,616,116 | 15.9 M to 15.6 M (-1.78 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 12,050,547 | 12.3 M to 12.1 M (-1.78 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,989 | 0 | 5,989 | 0 to 6 K |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,898,335 | 16.2 M to 15.9 M (-1.74 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 12,268,328 | 12.5 M to 12.3 M (-1.74 %) |
May 26 2020 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | A | 37.06 | 28,888 | 1,070,589 | 28,888 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,222,222 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 555,555 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 13,333,332 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,222,222 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 555,555 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 13,333,332 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 11,111,110 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 11,111,110 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | P | 20.00 | 1,000,000 | 20,000,000 | 1,000,000 | 0 to 1000 K |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | P | 20.00 | 1,000,000 | 20,000,000 | 1,000,000 | 0 to 1000 K |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 15,555,554 | 0 | 15,555,554 | 0 to 15.6 M |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 15,555,554 | 0 | 15,555,554 | 0 to 15.6 M |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 11,666,665 | 0 | 12,111,109 | 444.4 K to 12.1 M (+2,625.00 %) |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 11,666,665 | 0 | 12,111,109 | 444.4 K to 12.1 M (+2,625.00 %) |
Page: 1